KMT2C promoter methylation in plasma‐circulating tumor DNA is a prognostic biomarker in non‐small cell lung cancer

por Mastoraki, Sofia, Balgkouranidou, Ioanna, Tsaroucha, Emily, Klinakis, Apostolos, Georgoulias, Vassilis, Lianidou, Evi
Publicado 2020